Brainstorm Cell Therapeutics Inc. BCLI
Performance
| Periode | BCLI | BLRX | IKNA | APLT | CLNN | AMLX | CASI |
|---|---|---|---|---|---|---|---|
| 6M | -8.20 % | 42.18 % | 2.88 % | 153.04 % | 183.66 % | 290.68 % | 1.54 % |
| YTD | -67.29 % | -61.74 % | -13.33 % | 4.69 % | 59.46 % | 264.71 % | -33.56 % |
| 1Y | -68.04 % | -78.77 % | -22.70 % | -89.42 % | 49.48 % | 298.32 % | -65.98 % |
| 3Y | -98.69 % | -88.91 % | -70.33 % | 65.49 % | -70.77 % | -59.86 % | -16.81 % |
| 5Y | -99.72 % | -94.04 % | -95.53 % | -96.12 % | -96.01 % | -21.08 % | -88.75 % |
| 10Y | -98.29 % | -99.56 % | -95.53 % | -90.00 % | -95.59 % | -21.08 % | -80.59 % |
| From the beginning | -72.34 % | -99.88 % | -95.53 % | -90.00 % | -95.59 % | -21.08 % | -99.89 % |